Nplate Disease Interactions
There are 3 disease interactions with Nplate (romiplostim).
Romiplostim (applies to Nplate) leukemia
Major Potential Hazard, Moderate plausibility. Applicable conditions: Myelodysplastic Disease
Progression from myelodysplastic syndromes (MDS) to acute myelogenous leukemia (AML) has been observed in clinical trials with romiplostim. This drug is not indicated for the treatment of thrombocytopenia due to MDS or any other cause other than chronic ITP.
Romiplostim (applies to Nplate) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
No clinical studies with romiplostim have been conducted in patients with hepatic impairment.
Romiplostim (applies to Nplate) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
No clinical studies with romiplostim have been conducted in patients with renal impairment.
Switch to professional interaction data
Nplate drug interactions
There are 9 drug interactions with Nplate (romiplostim).
More about Nplate (romiplostim)
- Nplate consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (11)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: platelet-stimulating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.